Video: FDA Approves Hologic's Adiana(R) Permanent Contracept...(erm contraception needs. During ...),Health

During the Adiana procedure, a slender, flexible instrument is passed through the body's natural openings to deliver a low level of radiofrequency (RF) energy to a small section of each fallopian tube. A tiny, soft insert, about the size of a grain of rice, is then placed in each fallopian tube in the location where the energy was applied. During the three months following the procedure, the patient continues to use temporary birth control while new tissue grows in and around the Adiana inserts, eventually blocking the fallopian tubes. At three months, a special x-ray test (called a hysterosalpingogram or HSG) is performed to confirm the fallopian tubes are completely blocked and the patient may begin relying on Adiana for permanent contraception.

"This is another significant milestone for Hologic and our GYN surgical products business," said Tony Kingsley. "With FDA approval of the Adiana system, we are now able to provide physicians with another non-hormone, minimally-invasive therapy that addresses a significant issue for women in their post-childbearing years."

(1) January 2009, "U.S. Markets for Women's Health Devices," iData Research, Vancouver, British Columbia, Canada. iData is an international market research and consulting group.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecu
'/>"/>